CLVLF

 
Ordinary Shares International Reporting
OTC Pink Current Information
Contact Info
  • Level 5
  • 160 Queen Street
  • Melbourne, VIC 3000
  • Australia

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
CIK 0001290877
Fiscal Year End 6/30
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: Australia
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Philippe Wolgen CEO
Darren Keamy CFO
Colin Mackie Director, Bus. Dev.
Company Directors
Philippe Wolgen
Company Notes
  • Formerly=EpiTan Ltd. until 3-06
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
CLVLF Security Details Other Company Securities
Share Structure
Market Value1 $218,618,400 a/o Dec 07, 2016
Authorized Shares Not Available
Outstanding Shares 38,220,000 a/o Dec 31, 2013
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
CUV - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 915 (-81.62%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security